TMRW Vault® Granted CE Marking as Class IIa Medical Device in the EU

TMRW Vault® Secures CE Marking as a Class IIa Medical Device

In a significant advancement for reproductive health technology, Reprotech recently announced that its innovative TMRW Vault® has officially obtained the CE marking as a Class IIa medical device under the European Union's Medical Device Regulation (EU MDR 2017/745). This recognition not only affirms the device's compliance with stringent European regulations but also enhances its potential for commercialization across various international markets that recognize the CE designation.

The Importance of CE Marking

The CE marking is crucial as it signifies that a product meets the essential health and safety requirements set by the European legislation. For medical devices like TMRW Vault®, this certification is vital. It allows healthcare providers and clinics specializing in fertility treatments to incorporate this advanced technology into their operations, thereby improving the care they offer to their patients. This is particularly timely, as the demand for efficient and reliable reproductive health solutions has seen a marked increase.

Sophisticated Features of TMRW Vault®

The TMRW Vault® is designed to revolutionize the way fertility clinics manage and store reproductive specimens. It incorporates a digital storage chain, advanced monitoring capabilities, and scalable cryostorage solutions, all aimed at minimizing risk while bolstering specimen traceability and supporting clinic growth.

Key features of the TMRW Vault® include:
1. Cryogenic Storage: The TMRW Vault Freezer is specifically engineered to store oocytes, embryos, and sperm in liquid nitrogen, facilitating specimen identification and traceability.
2. User-Friendly Workstation: The integrated TMRW Vault Workstation allows users to easily transfer specimens to and from the TMRW Vault Freezer and manage orders through an intuitive software interface.
3. Real-Time Monitoring: Through the TMRW Overwatch® software, clinics can conduct thousands of system checks daily, ensuring that storage conditions are continually optimized and reliable.
4. Scalable Capacity: Remarkably, one Vault unit can contain up to ten traditional Dewar vessels while occupying only about one-third of the physical space.
5. Seamless Integration: TMRW Vault® integrates smoothly with the broader ecosystem of TMRW services, providing a comprehensive, all-in-one solution for cryostorage needs.

Addressing Industry Challenges

As fertility clinics encounter rapidly growing volumes of frozen reproductive tissues, the demand for safe, scalable, and traceable storage solutions becomes increasingly essential. Historically, these clinics have relied heavily on manual storage systems that can lead to operational inefficiencies and greater potential for human error. TMRW Vault® takes a significant step forward by modernizing this process.

By combining advanced on-site cryostorage infrastructure with TMRW's patented sample management software (ivfOS), the TMRW Vault® provides an integrated solution that enables digital sample identification, continuous monitoring, real-time inventory management, and secure digital tracking of specimen flows, thereby significantly enhancing the overall safety and efficiency of fertility clinics.

A Promising Future for Reprotech

This significant milestone follows the recent business merger between Reprotech and TMRW Life Sciences, completed in April 2026. This partnership merges decades of experience in cryostorage and a national network of biorepositories in the U.S. with cutting-edge digital sample management technologies. Furthermore, Reprotech's acquisition of IMT Matcher in June 2025 is set to create one of the most comprehensive ecosystems for reproductive health, offering clinics a complete package that includes sample record-keeping, digital traceability, cryostorage both on-site and off-site, as well as consent management and storage compliance.

Reprotech, a leading force in the protection, management, and long-term storage of reproductive specimens, has a commitment to delivering innovative solutions that enhance safety and compliance. With a portfolio that includes seven purpose-built biorepositories, advanced cryostorage management technologies, and global digital tracking solutions, Reprotech is setting new standards in the preservation of vital reproductive materials for the future.

For more information, please visit Reprotech's website.